Financial reports
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
24 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
10-Q
2021 Q2
Quarterly report
4 Aug 21
10-Q
2021 Q1
Quarterly report
5 May 21
10-K
2020 FY
Annual report
24 Feb 21
10-Q
2020 Q3
Quarterly report
3 Nov 20
10-Q
2020 Q2
Quarterly report
5 Aug 20
Current reports
8-K
Entry into a Material Definitive Agreement
21 Oct 22
8-K
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
19 Oct 22
8-K
Amendments to Articles of Incorporation or Bylaws
18 Oct 22
8-K
Entry into a Material Definitive Agreement
12 Oct 22
8-K
Special Meeting of Securityholders
7 Oct 22
8-K
Zymeworks Reminds Shareholders to Vote FOR its Redomicile
4 Oct 22
8-K
Zymeworks Announces Participation in Upcoming Investor Conferences and Early Research & Development Day
3 Oct 22
8-K
Independent Proxy Advisory Firm ISS Recommends a Vote FOR the Zymeworks Redomicile
26 Sep 22
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
22 Sep 22
8-K
Regulation FD Disclosure
16 Sep 22
Registration and prospectus
15-12G
Securities registration termination
24 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Oct 22
POSASR
Automatic shelf registration (post-effective amendment)
13 Oct 22
25-NSE
Exchange delisting
13 Oct 22
25-NSE
Exchange delisting
13 Oct 22
425
Business combination disclosure
12 Oct 22
425
Business combination disclosure
7 Oct 22
Proxies
Other
CERT
Certification of approval for exchange listing
14 Jun 22
UPLOAD
Letter from SEC
26 Apr 21
CORRESP
Correspondence with SEC
23 Apr 21
UPLOAD
Letter from SEC
14 Apr 21
CT ORDER
Confidential treatment order
28 Jan 20
CT ORDER
Confidential treatment order
28 Jan 20
CT ORDER
Confidential treatment order
28 Jan 20
CT ORDER
Confidential treatment order
28 Jan 20
CT ORDER
Confidential treatment order
28 Jan 20
CT ORDER
Confidential treatment order
28 Jan 20
Ownership
SC 13G/A
BANK OF AMERICA CORP /DE/
14 Feb 23
SC 13G/A
WELLINGTON MANAGEMENT GROUP LLP
6 Feb 23
4
Neil Josephson
14 Nov 22
SC 13G
Redmile Group, LLC
8 Aug 22
4
Paul Andrew Moore
19 Jul 22
3
Paul Andrew Moore
19 Jul 22
4
Neil Josephson
5 Jul 22
4
Neil A Klompas
5 Jul 22
SC 13D/A
All Blue Falcons FZE
26 May 22
SC 13D/A
All Blue Falcons FZE
20 May 22